Bynder Kicks Off Peak Shopping Season by Serving a Record 6 Billion Assets - Powering Exceptional Global Content Experiences Online
Bynder, a global leader in AI-powered enterprise DAM, has helped a number of global brands break Black Friday and Cyber Monday records by delivering exceptional content experiences at scale across a number of worldwide e-commerce channels.
During the seven day period (November 27 - Dec 2 2024) which included Black Friday, Small Business Saturday, and Cyber Monday, Bynder’s Content Experiences (CX) for Omnichannel solution was responsible for serving more than 6 billion assets to over 70,000 websites, with more than 4.5 billion asset transformations undertaken.
The figures represent a 15% increase in assets delivered vs 2023, plus 67% more assets were delivered through CX for Omnichannel on Black Friday than an average day in 2024.
Customers such as Sur La Table, Bose, Raymour & Flanigan and Puma used CX for Omnichannel to deliver targeted and optimized content at scale to their digital channels over the busiest shopping days. Bynder customers were able to utilize the assets stored in their Bynder DAM and transform and deliver them to their digital channels, including their website, e-commerce sites, emails and social media.
Bynder’s DAM sits at the heart of a brand’s martech stack as the system of record for digital assets, while Bynder’s CX for Omnichannel solution is the delivery technology that connects the DAM to a brand’s tech ecosystem and automates delivering optimized assets for each digital channel in real time.
For consumer brands that are delivering seasonal shopping content across a number of e-commerce platforms, Bynder’s solution can transform, optimize and deliver targeted content experiences based on the channel and audience automatically, that boost return on investment all while ensuring brand consistency, improved website performance and increase in conversions for e-commerce sites.
According to a NielsenIQ study analyzed by Barcelona's OBS Business School, Black Friday has become one of the most anticipated European retail periods in the run-up to the holiday season, with 61% of consumers in Spain, the UK, Italy, France, and Germany expected to have participated in Black Friday. While in the US, a record 200.4 million consumers shopped over the five-day holiday weekend from Thanksgiving Day through Cyber Monday, surpassing last year’s record of 196.7 million.
When creating and managing seasonal assets, a survey by Bynder revealed that 51% of marketers agreed that more marketing assets are required for Black Friday than any other seasonal holiday. The biggest challenge stated for just over one in three (36%) respondents was managing the number of assets they were creating for the peak shopping season.
Sur La Table, a retailer known for a variety of upscale cooking and dining supplies, is one such brand scaling its content delivery through Bynder during the holiday peak period.
Blake Bakanoff, VP of Creative at Sur La Table, said, “A good tool improves the way we work. A great partner improves the way we think, make and move.At Sur La Table, bringing value to our customers, by creating exceptional culinary content, lies at the core of our brand. We’re “Makers” at heart, and Bynder’s CX for Omnichannel solution empowers us to create, adapt, and deliver a wealth of custom content tailored to every channel—whether it’s showcasing thoughtful gift ideas on Instagram, sharing original holiday recipes through email, or engaging customers as they explore our website. By connecting our teams and external partners to our extensive content catalog delivering 165M+ assets, Bynder enables us to inspire and delight our customers with curated, memorable experiences during the peak holiday season."
Peter-Paul Houtman, CTO at Bynder, said: “The period between Thanksgiving and Cyber Monday represents some of the busiest days for e-commerce retailers. The volume of shoppers has increased over time and so has the volume of products that are available at a discount. E-commerce retailers are dealing with a higher volume of transactions and they need a scalable AI-powered enterprise grade platform like Bynder’s DAM, as well as its Content Experiences (CX) for Omnichannel solution, to deliver exceptional content experiences for their customers during these peak times.
“A unified omnichannel approach in terms of managing assets and delivering assets digitally ensures no opportunity is missed during peak retail seasons and by using Content Experiences for Omnichannel, leading brands can supercharge their marketing strategies and boost engagement by creating targeted content experiences across a number of digital touchpoints, improving website performance and conversions to bring real return-on-investment to businesses.”
For more information on Bynder’s DAM, please visit: https://www.bynder.com/en/products/digital-asset-management/ and for more information on Content Experiences (CX) for Omnichannel, please visit: https://www.bynder.com/en/products/content-experiences-for-omnichannel/
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209828157/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom